Interleukin-6 is a major effector molecule of short-term G-CSF treatment inducing bone metabolism and an acute-phase response

Author: Carstanjen D.   Regenfus M.   Muller C.   Salama A.  

Publisher: Elsevier

ISSN: 0301-472X

Source: Experimental Hematology, Vol.29, Iss.7, 2001-07, pp. : 812-821

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content